Tacalyx

Tacalyx

Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist

Tacalyx Company information

Edit
Growth stage
  • Edit
loading funding rounds…

Recent News about Tacalyx

Edit
Are you an employee or an investor of this company?
Add your profile